JenaValve o Khetha Kari Moore e le Ofisiri e ka Sehloohong ea Lichelete

IRVINE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("JenaValve kapa "Company"), moqapi le moetsi oa litsamaiso tse fapaneng tsa transcatheter aortic valve replacement (TAVR), kajeno o phatlalalitse ho khethoa ha Kari Moore e le Ofisiri e ka Sehloohong ea Lichelete ea k'hamphani e sebetsang ka la 10 Motšeanong, 2022. "Re thabetse ho amohela Kari sehlopheng sa JenaValve," ho boletse CEO oa JenaValve John Kilcoyne." Kari o na le lilemo tse fetang 35 tsa phihlelo e batsi ea lichelete le ea ts'ebetso sesebelisoa sa bongaka le liindasteri tsa tlhokomelo ea bophelo. Tsebo e pharalletseng ea Kari le boitseanape ba indasteri li tla re thusa ho tsoela pele ho phethahatsa leano la rona la bongaka le ho ntšetsa pele Trilogy ea rona bakeng sa kalafo ea lefu la aortic valve ® Boiteko ba Khoebo bakeng sa Lits'ebetso tsa Heart Valve. Mofumahatsana Moore o ikopanya le JenaValve ka mora ho sebetsa e le Mohlanka e Moholo wa Boikarabello bakeng sa Envista Holdings Corporation, khamphani ya lefatshe ka bophara ya dihlahiswa tsa meno, moo a neng a ikarabella bakeng sa mesebetsi ya lefatshe lohle ya diakhaonto, ditjhelete le ditshebeletso tse arolelanoang.Pele a kenela Envista Holdings Corporation, Mme Moore e ne e le Hlooho Ofisiri ea Likarabello ea Applied Medical Corporation, k'hamphani ea lefats'e ea lisebelisoa tsa bongaka e fanang ka theknoloji le tharollo bakeng sa ho buuoa ho fokolang le ho akaretsang. Moore o qalile mesebetsi ea hae PricewaterhouseCoopers, moo a neng a sebetsa e le molekane oa tlhahlobo ea lichelete, a sebetsa ka thata indastering ea saense ea bophelo. Nakong ea mosebetsi oa hae oa lilemo tse 20, Mofumahatsana Moore o ile a isa lik'hamphani tse ngata phatlalatsa 'me a li thusa ka ho reka, ho arola chelete le ho fana ka likoloto. Kari o tšoere ke BA in Business Administration ho tsoa Univesithing ea Southern California mme ke CPA seterekeng sa California. "Ke thabetse ho ba karolo ea JenaValve ka nako e mahlonoko hakana," ho boletse Mme Moore. "Ke thabetse ho sebetsa le sehlopha sohle sa JenaValve ha re ntse re tsoela pele ho phethahatsa maqheka a rona a ho hōla le ho theha boleng ha re ntse re ntlafatsa bophelo ba bakuli." Mabapi le JenaValve JenaValve Technology, Inc., ntlo-khōlō e Irvine, California, e nang le libaka tsa Leeds, UK le Munich, Jeremane, e hlahisa le ho etsa lisebelisoa tsa transcatheter aortic valve replacement (TAVR) bakeng sa phekolo ea bakuli ba nang le lefu la aortic valve.JenaValve e tšehetsoa ke Bain Capital Life Sciences le Cormorant Asset Management, hammoho le batseteli ba Europe le Asia ba kenyelletsang Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners le Peijia Medical Limited (HKEx: 9996) . United States: Tlhokomeliso - Thepa ea Lipatlisiso.E thibetsoe ke molao oa federal (kapa US) bakeng sa tšebeliso ea lipatlisiso feela.